Alternative to Rituximab Therapy for a Patient with Ankylosing Spondylitis Who Was Unable to Continue Anti-TNF Therapy

被引：0

作者：

Katsuyama, Eri ^{[1
]}

Wakabayashi, Hiroshi ^{[2
]}

Sada, Ken-ei ^{[1
]}

Hiramatsu, Sumie ^{[1
]}

Miyawaki, Yoshia ^{[1
]}

Morishita, Michiko ^{[1
]}

Ohashi, Keiji ^{[1
]}

Watanabe, Haruki ^{[1
]}

Katsuyama, Takayuki ^{[1
]}

Zeggar, Sonia ^{[1
]}

Narazaki, Mariko ^{[1
]}

Tatebe, Noriko ^{[1
]}

Watanabe, Katsue S. ^{[1
]}

Kawabata, Tomoko ^{[1
]}

Wada, Jun ^{[1
]}

机构：

[1] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama 7008558, Japan

[2] Okayama Municipal Hosp, Okayama 7000962, Japan

来源：

ACTA MEDICA OKAYAMA | 2017年 / 71卷 / 05期

关键词：

ankylosing spondylitis; rituximab; treatment; OPEN-LABEL; INFLIXIMAB; TRIAL; INFLAMMATION; ABATACEPT;

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

We herein present a case of a 38-year-old man who had bamboo spine and severe sacroiliitis and who was diagnosed with ankylosing spondylitis (AS). Infliximab (IFX) markedly improved the axial symptom but was discontinued due to the side effect of peripheral neuropathy. Switching from IFX to etanercept worsened the side effect. Rituximab (RTX) administration elicited a good response without side effects. RTX might be a suitable option for AS therapy when TNF inhibitors are difficult to use.

引用

页码：445 / 448

页数：4

共 50 条

[31] Effectiveness of a supervised group exercise therapy based on the biopsychosocial model introduced simultaneously with anti-TNF therapy in anti-TNF-naive patients with active ankylosing spondylitis
Karaca, Nur Banu
Unal, Edibe
Karakaya, Jale
Kalyoncu, Umut
Kiraz, Sedat
TURKISH JOURNAL OF MEDICAL SCIENCES, 2022, 52 (03) : 667 - +
[32] The Impact of Anti-TNF Therapy on CD4+and CD8+Cell Subsets in Ankylosing Spondylitis
Dulic, Sonja
Vasarhelyi, Zsofia
Bajnok, Anna
Szalay, Balazs
Toldi, Gergely
Kovacs, Laszlo
Balog, Attila
PATHOBIOLOGY, 2018, 85 (03) : 201 - 210
[33] Anti-TNF alpha in the treatment of rheumatoid arthritis and ankylosing spondylitis
Lanfant-Weybel, Karine
Lequerre, Thierry
Vittecoq, Olivier
PRESSE MEDICALE, 2009, 38 (05): : 774 - 787
[34] Anti-TNF Therapy Regulates Phagosome Pathway by Inhibiting NCF4 Expression to Treat Ankylosing Spondylitis
Liu, Sha
Zhu, Hui
JOURNAL OF MUSCULOSKELETAL & NEURONAL INTERACTIONS, 2023, 23 (03) : 355 - 364
[35] Effect of anti-TNF treatment on sleep problems in ankylosing spondylitis
Karadag, Omer
Nakas, Dilek
Kalyoncu, Umut
Akdogan, Ali
Kiraz, Sedat
Ertenli, Ihsan
RHEUMATOLOGY INTERNATIONAL, 2012, 32 (07) : 1909 - 1913
[36] Effect of anti-TNF treatment on sleep problems in ankylosing spondylitis
Ömer Karadağ
Dilek Nakas
Umut Kalyoncu
Ali Akdoğan
Sedat Kiraz
İhsan Ertenli
Rheumatology International, 2012, 32 : 1909 - 1913
[37] Does anti-tnf therapy cause any change in platelet activation in ankylosing spondylitis patients?A comparative study
Hüseyin Örüm
Gülsüm Emel Pamuk
Ömer Nuri Pamuk
Muzaffer Demir
Burhan Turgut
Journal of Thrombosis and Thrombolysis, 2012, 33 : 154 - 159
[38] Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
Xenofon Baraliakos
Joachim Listing
Jan Brandt
Martin Rudwaleit
Joachim Sieper
Juergen Braun
Arthritis Research & Therapy, 7
[39] Pneumonia complicated by SARS-coV-2 infection in three patients with ankylosing spondylitis who are on anti-TNF therapy: Case-based review
Kaymaz, Serdar
Karasu, Ugur
Cobankara, Veli
Alkan, Hakan
Ulutas, Firdevs
INDIAN JOURNAL OF RHEUMATOLOGY, 2020, 15 (04) : 341 - 346
[40] ASDAS high disease activity versus BASDAI elevation in patients with ankylosing spondylitis as selection criterion for anti-TNF therapy
Vastesaeger, Nathan
Vander Cruyssen, Bert
Mulero, Juan
Gratacos Masmitja, Jordi
Zarco, Pedro
Almodovar, Raquel
Font, Pilar
Juanola, Xavier
Collantes-Estevez, Eduardo
REUMATOLOGIA CLINICA, 2014, 10 (04): : 204 - 209

← 1 2 3 4 5 →